391 related articles for article (PubMed ID: 19855306)
21. Lung function, haemoglobin and irreversibly sickled cells in sickle cell patients.
Jaja SI; Opesanwo O; Mojiminiyi FB; Kehinde MO
West Afr J Med; 2000; 19(3):225-9. PubMed ID: 11126090
[TBL] [Abstract][Full Text] [Related]
22. A method of HbF determination for potential use in underdeveloped countries.
Schumacher SN; Randolph TR
Clin Lab Sci; 2012; 25(4):212-8. PubMed ID: 23330510
[TBL] [Abstract][Full Text] [Related]
23. [Influence of fetal haemoglobin rate (FHb) on the oxidizing stress in homozygote sickle cell patient living in Abidjan, Côte-d'Ivoire].
Nacoulma EW; Sawadogo D; Sakandé J; Mansour A; Hien FH; Sangaré A; Sess ED
Bull Soc Pathol Exot; 2006 Oct; 99(4):241-4. PubMed ID: 17111970
[TBL] [Abstract][Full Text] [Related]
24. Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood.
Meier ER; Byrnes C; Weissman M; Noel P; Luban NL; Miller JL
Pediatr Blood Cancer; 2011 Jan; 56(1):103-9. PubMed ID: 21108444
[TBL] [Abstract][Full Text] [Related]
25. Rapid quantitation of hemoglobin S by isoelectric focusing.
Reddy MN; Franciosi RA
Ann Clin Lab Sci; 1994; 24(5):401-6. PubMed ID: 7529472
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
Marcus SJ; Kinney TR; Schultz WH; O'Branski EE; Ware RE
Am J Hematol; 1997 Jan; 54(1):40-6. PubMed ID: 8980259
[TBL] [Abstract][Full Text] [Related]
27. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
Koc A; Gumruk F; Gurgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
Conran N; Fattori A; Saad ST; Costa FF
Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
[TBL] [Abstract][Full Text] [Related]
29. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
Ballas SK; McCarthy WF; Guo N; Brugnara C; Kling G; Bauserman RL; Waclawiw MA
Hemoglobin; 2010; 34(5):424-9. PubMed ID: 20854115
[TBL] [Abstract][Full Text] [Related]
30. Fetal hemoglobin response to hydroxyurea in Yemeni sickle cell disease patients.
Al-Nood HA; Al-Khawlani MM; Al-Akwa A
Hemoglobin; 2011; 35(1):13-21. PubMed ID: 21250877
[TBL] [Abstract][Full Text] [Related]
31. Determinants of fetal hemoglobin response to hydroxyurea.
Steinberg MH
Semin Hematol; 1997 Jul; 34(3 Suppl 3):8-14. PubMed ID: 9317196
[TBL] [Abstract][Full Text] [Related]
32. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS
Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of F cells in sickle cell disorders by flow cytometry -- comparison with the Kleihauer-Betke's slide method.
Italia KY; Colah R; Mohanty D
Int J Lab Hematol; 2007 Dec; 29(6):409-14. PubMed ID: 17988294
[TBL] [Abstract][Full Text] [Related]
34. Erythrocyte composition in sickle-cell anemia.
Hellerstein S; Bunthrarungroj T
J Lab Clin Med; 1974 Apr; 83(4):611-24. PubMed ID: 4817782
[No Abstract] [Full Text] [Related]
35. Influence of plasma and red cell factors on the rheologic properties of oxygenated sickle blood during clinical steady state.
Morris CL; Gruppo RA; Shukla R; Rucknagel DL
J Lab Clin Med; 1991 Oct; 118(4):332-42. PubMed ID: 1940575
[TBL] [Abstract][Full Text] [Related]
36. Therapies to increase fetal hemoglobin in sickle cell disease.
Steinberg MH
Curr Hematol Rep; 2003 Mar; 2(2):95-101. PubMed ID: 12901139
[TBL] [Abstract][Full Text] [Related]
37. Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.
Adekile A; Menzel S; Gupta R; Al-Sharida S; Farag A; Haider M; Akbulut N; Mustafa N; Thein SL
Am J Hematol; 2015 Jul; 90(7):E138-9. PubMed ID: 25851995
[No Abstract] [Full Text] [Related]
38. Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use.
Green NS; Manwani D; Qureshi M; Ireland K; Sinha A; Smaldone AM
Pediatr Blood Cancer; 2016 Dec; 63(12):2146-2153. PubMed ID: 27573582
[TBL] [Abstract][Full Text] [Related]
39. The clinical pathophysiology of sickle cell disease.
Embury SH
Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018
[TBL] [Abstract][Full Text] [Related]
40. Method-dependent Discrepancies in Fetal Hemoglobin Quantification in Patients With Hemoglobin S.
Creary SE; Pyle-Eilola AL; Varga E; Cotten SW; S Lorey T; Holmes DT; Greene DN
J Pediatr Hematol Oncol; 2016 Jul; 38(5):402-5. PubMed ID: 27164532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
